CRSP icon

CRISPR Therapeutics

434 hedge funds and large institutions have $3.7B invested in CRISPR Therapeutics in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 129 increasing their positions, 115 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
434
Holders Change
+1
Holders Change %
+0.23%
% of All Funds
7.5%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.14%
New
58
Increased
129
Reduced
115
Closed
50
Calls
$223M
Puts
$213M
Net Calls
+$10.5M
Net Calls Change
+$83K
Name Holding Trade Value Shares
Change
Shares
Change %
PCFFS
376
Pacific Center for Financial Services
California
$5K
PGAM
377
Princeton Global Asset Management
New Jersey
$5K
BA
378
Bellwether Advisors
Nebraska
$5K
RA
379
Rise Advisors
New York
$4K
BFPW
380
BOK Financial Private Wealth
Colorado
$4K
LF
381
Lee Financial
Texas
$4K
DAC
382
Dividend Assets Capital
South Carolina
$4K
TFA
383
Toth Financial Advisory
Virginia
$4K
FGAM
384
Financial Gravity Asset Management
Texas
$3.51K +$3.51K +1,105 New
QCG
385
Quadrant Capital Group
Ohio
$3K -$255 -4 -8%
BCMLT
386
Beacon Capital Management LLC (Tennessee)
Tennessee
$3K
CA
387
Clearstead Advisors
Ohio
$3K
First Manhattan
388
First Manhattan
New York
$3K
AAP
389
Arax Advisory Partners
Colorado
$3K
CCMW
390
Cypress Capital Management (Wyoming)
Wyoming
$3K
MWA
391
Moser Wealth Advisors
Washington
$3K
LFA
392
Level Financial Advisors
New York
$3K
WBC
393
West Branch Capital
Massachusetts
$3K
GRP
394
Global Retirement Partners
California
$3K
MS
395
Mizuho Securities
Japan
$3K +$65 +1 +2%
BWL
396
Bogart Wealth LLC
Virginia
$3K +$3K +50 New
WPA
397
West Paces Advisors
Georgia
$2.29K
ADL
398
Asset Dedication LLC
California
$2K
GI
399
Gradient Investments
Minnesota
$2K
PP
400
Pacifica Partners
Canada
$2K